GOOD NEWS – Growth and jobs in regional Pharma manufacturing – the deal on new Fawdon Biopark, Northumbria Park, agreed – an acknowledgement of the value of Innovate UK – the key role of the pharma and biopharma in the growth in the Northern Powerhouse – the National Biologics Manufacturing Centre off to flying start.
The National picture.
Ian Shott reports that the effects on Innovate UK of the change in government, the Nurse Review, and CSR are almost bedded down. Innovate UK is acknowledged as the glue of the innovation system in the UK. The emphasis will become SME support and productivity.
There is still more to do in communicating an understanding of what pharma and biopharma are doing in the north. This ties in with the question on the Chancellor’s mind: what can the manufacturing in North do for the UK?
We in First for Pharma have a special role in contributing to a full understanding of the contribution that pharma and bio are making to connect the story of the Northern Powerhouse. We must share the stories of advanced processing, the clear gains in productivity; the North must tell the story about its growth. Real growth is happening in the sector in the North East as reported by a large proportion of company leaders at the dinner, reflected in notable increases in their workforces. And the growing of SME’s is evidenced by strong interest in the Fawdon Biopark.
Northumbria Park, the North East’s grow-on space for biotech/bioscience companies.
Northumbria Park in Fawdon, Newcastle upon Tyne’s newest Science Park opens soon. Mike Delroy of Sanofi reported on the successful repurposing of the previous Sanofi site at Fawdon with the October agreement with Discovery Park Ltd. You can also see the press report in the Chronicle on 20 November 2015. This successfully fulfils the desire of the original site owners for a legacy of employment at the site.
Who will be moving there? Agreements are in place with three tenants and there will be an announcement before the end of the year about a generic drugs manufacturer who is intending to use a third of the site. Talks are on the go with at least four other potential bioscience/biotech tenants.
The National Biologics Manufacturing Centre
NBMC, opened its doors on 30 September 2015 and it already has a very full pipeline of projects as described to us in detail by Jonathan Robinson. Unique facilities? They have a process development facility for nano pharmaceuticals – the only one in Europe – and the NBMC is doing the process development work on a gold nanoparticle application with a European company. NBMC has a tried and tested innovation process, specialist analytics, process development, supply chain development and scale-up; there are facilities for parallel testing which supports the practical philosophy of failing fast and failing early to quickly work out which candidates will proceed. We are delighted by NBMC’s extraordinary progress.
The next First for Pharma dinner is planned for Darlington, NBMC’s home.